Sarah R Gillett1, Rebekah H Boyle2, Neil A Zakai3, Leslie A McClure4, Nancy S Jenny2, Mary Cushman5. 1. Department of Medicine, University of Vermont College of Medicine, 208 South Park Dr., Colchester, VT 05446, USA. 2. Department of Pathology, University of Vermont College of Medicine, 208 South Park Dr., Colchester, VT 05446, USA. 3. Department of Medicine, University of Vermont College of Medicine, 208 South Park Dr., Colchester, VT 05446, USA; Department of Pathology, University of Vermont College of Medicine, 208 South Park Dr., Colchester, VT 05446, USA. 4. University of Alabama at Birmingham, 1665 University Blvd., Birmingham, AL 35233, USA. 5. Department of Medicine, University of Vermont College of Medicine, 208 South Park Dr., Colchester, VT 05446, USA; Department of Pathology, University of Vermont College of Medicine, 208 South Park Dr., Colchester, VT 05446, USA. Electronic address: mary.cushman@uvm.edu.
Abstract
OBJECTIVES: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study is a prospective cohort of 30,239 Americans in the contiguous United States; the first of this scale to use home visits to obtain, process, and ship biologic samples to a core laboratory. Pre-analytical factors resulting from this study design may affect the results of some laboratory assays. We investigated the impact of REGARDS processing on a variety of analytes. DESIGN AND METHODS: In REGARDS, blood samples were processed in the field by technicians who were trained on standardized methods for phlebotomy and sample processing. Field processing included centrifugation using varying non-uniform equipment and shipping overnight on ice to the University of Vermont, where samples were re-centrifuged for 30,000 ×g-minutes and stored at -80 °C. We assessed the effects of REGARDS sample handling by processing split samples from 20 volunteers using either ideal procedures or simulated REGARDS procedures. Assays for 19 analytes for potential study in REGARDS were then run on both samples and results compared. RESULTS: Spearman correlation coefficients for analytes measured in ideal versus REGARDS processed samples ranged from 0.11 to 1.0. Thirteen of 19 analytes were highly correlated (>0.75), but platelet proteins were more variable. CONCLUSIONS: Simulation of non-optimal field processing and shipment to a central laboratory showed high variability in analytes released by platelets. The majority of other analytes produced valid results, but platelet contamination in REGARDS samples makes measurement of platelet proteins unadvisable in these samples. Future analytes considered by REGARDS or similar studies should undergo similar pilot testing.
OBJECTIVES: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study is a prospective cohort of 30,239 Americans in the contiguous United States; the first of this scale to use home visits to obtain, process, and ship biologic samples to a core laboratory. Pre-analytical factors resulting from this study design may affect the results of some laboratory assays. We investigated the impact of REGARDS processing on a variety of analytes. DESIGN AND METHODS: In REGARDS, blood samples were processed in the field by technicians who were trained on standardized methods for phlebotomy and sample processing. Field processing included centrifugation using varying non-uniform equipment and shipping overnight on ice to the University of Vermont, where samples were re-centrifuged for 30,000 ×g-minutes and stored at -80 °C. We assessed the effects of REGARDS sample handling by processing split samples from 20 volunteers using either ideal procedures or simulated REGARDS procedures. Assays for 19 analytes for potential study in REGARDS were then run on both samples and results compared. RESULTS: Spearman correlation coefficients for analytes measured in ideal versus REGARDS processed samples ranged from 0.11 to 1.0. Thirteen of 19 analytes were highly correlated (>0.75), but platelet proteins were more variable. CONCLUSIONS: Simulation of non-optimal field processing and shipment to a central laboratory showed high variability in analytes released by platelets. The majority of other analytes produced valid results, but platelet contamination in REGARDS samples makes measurement of platelet proteins unadvisable in these samples. Future analytes considered by REGARDS or similar studies should undergo similar pilot testing.
Authors: Jennifer K Pai; Gary C Curhan; Carolyn C Cannuscio; Nader Rifai; Paul M Ridker; Eric B Rimm Journal: Clin Chem Date: 2002-10 Impact factor: 8.327
Authors: Virginia J Howard; Mary Cushman; Leavonne Pulley; Camilo R Gomez; Rodney C Go; Ronald J Prineas; Andra Graham; Claudia S Moy; George Howard Journal: Neuroepidemiology Date: 2005-06-29 Impact factor: 3.282
Authors: Robert C Kaplan; Gloria Y F Ho; XiaoNan Xue; Swapnil Rajpathak; Mary Cushman; Thomas E Rohan; Howard D Strickler; Philipp E Scherer; Kathryn Anastos Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-06 Impact factor: 4.254
Authors: S R Gillett; L A McClure; P W Callas; E L Thacker; F W Unverzagt; V G Wadley; A J Letter; M Cushman Journal: J Thromb Haemost Date: 2018-06-06 Impact factor: 5.824
Authors: Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman Journal: Clin Neuropsychol Date: 2015-05-15 Impact factor: 3.535
Authors: Wesley T O'Neal; Elsayed Z Soliman; George Howard; Virginia J Howard; Monika M Safford; Mary Cushman; Neil A Zakai Journal: Atherosclerosis Date: 2015-09-08 Impact factor: 5.162
Authors: Neil A Zakai; Nels C Olson; Suzanne E Judd; Dawn O Kleindorfer; Brett M Kissela; George Howard; Mary Cushman Journal: Thromb Haemost Date: 2017-07-06 Impact factor: 5.249
Authors: Sri Lekha Tummalapalli; Eric Vittinghoff; Deidra C Crews; Mary Cushman; Orlando M Gutiérrez; Suzanne E Judd; Holly J Kramer; Carmen A Peralta; Delphine S Tuot; Michael G Shlipak; Michelle M Estrella Journal: Am J Nephrol Date: 2020-04-29 Impact factor: 3.754
Authors: K K Landry; K S Alexander; N A Zakai; S E Judd; D O Kleindorfer; V J Howard; G Howard; M Cushman Journal: J Thromb Haemost Date: 2016-12-09 Impact factor: 5.824
Authors: K L Cheung; N A Zakai; P W Callas; G Howard; B K Mahmoodi; C A Peralta; S E Judd; M Kurella Tamura; M Cushman Journal: J Thromb Haemost Date: 2018-08-09 Impact factor: 5.824
Authors: Katharine L Cheung; Neil A Zakai; Aaron R Folsom; Manjula Kurella Tamura; Carmen A Peralta; Suzanne E Judd; Peter W Callas; Mary Cushman Journal: Am J Kidney Dis Date: 2017-01-23 Impact factor: 8.860
Authors: Yulia Khodneva; Anath Shalev; Stuart J Frank; April P Carson; Monika M Safford Journal: Diabetes Res Clin Pract Date: 2016-01-15 Impact factor: 5.602